{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:51:52Z","timestamp":1790682712197,"version":"4.1.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p>A 74-year-old man with metastatic castration-resistant prostate cancer underwent 2 cycles of [<jats:sup>177<\/jats:sup>Lu]Lu-prostate-specific membrane antigen (PSMA) therapy. Despite declining prostate-specific antigen (PSA) levels and pain relief throughout the first 4 months of [<jats:sup>177<\/jats:sup>Lu]Lu-PSMA therapy, follow-up [<jats:sup>68<\/jats:sup>Ga]Ga-PSMA PET\/CT revealed progressive skeletal involvement. A bone marrow biopsy confirmed fulminant metastatic castration-resistant prostate cancer infiltration. This case exemplifies PSA pseudoregression, where PSA suggests disease control while imaging shows progression. The patient\u2019s condition deteriorated, leading to intensive care admission and death.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005792","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T05:00:11Z","timestamp":1750136411000},"page":"791-792","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Short-term Prostate-specific Antigen Pseudoregression Following [177Lu]\u2013Prostate-specific Membrane Antigen Therapy"],"prefix":"10.1097","volume":"50","author":[{"given":"Ahmed Saad","family":"Abdlkadir","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine and PET\/CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazmi","family":"Kamal","sequence":"additional","affiliation":[{"name":"Department of Pathology, King Hussein Cancer Center (KHCC), Al-Jubeiha"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohannad","family":"Badarneh","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET\/CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0978-4716","authenticated-orcid":false,"given":"Akram","family":"Al-Ibraheem","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET\/CT"},{"name":"School of Medicine, University of Jordan, Amman, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"R1-20250630","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1200\/JCO.2015.64.2702","article-title":"Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the Prostate Cancer Clinical Trials Working Group 3","volume":"34","author":"Scher","year":"2016","journal-title":"J Clin Oncol"},{"key":"R2-20250630","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1055\/a-2311-5679","article-title":"Peculiar pattern of response following [225Ac] Ac-PSMA therapy: a case report with \u2018PSA pseudoregression\u2019response pattern","volume":"63","author":"Al-Ibraheem","year":"2024","journal-title":"Nuklearmedizin-NuclearMedicine"},{"key":"R3-20250630","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/pcan.2016.71","article-title":"Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL","volume":"20","author":"Bryce","year":"2017","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"R4-20250630","first-page":"14","article-title":"Painful boney metastases","volume":"1","author":"Smith","year":"2012","journal-title":"Ann Palliat Med"},{"key":"R5-20250630","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/RLU.0000000000002833","article-title":"Efficacy and safety of 177Lu-PSMA-617 radioligand therapy in metastatic castration-resistant prostate cancer patients","volume":"45","author":"Yadav","year":"2020","journal-title":"Clin Nucl Med"},{"key":"R6-20250630","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1007\/s00259-023-06119-1","article-title":"Extended therapy with [177Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer","volume":"50","author":"Mader","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R7-20250630","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/RLU.0000000000001195","article-title":"Positive influence of 177Lu PSMA-617 therapy on bone marrow depression caused by metastatic prostate cancer","volume":"41","author":"Schlenkhoff","year":"2016","journal-title":"Clin Nucl Med"},{"key":"R8-20250630","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clgc.2011.04.003","article-title":"Prolonged remission of fulminant castrate-resistant prostate cancer: a case report","volume":"9","author":"Bilen","year":"2011","journal-title":"Clin Genitourin Cancer"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T16:01:29Z","timestamp":1751299289000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005792"}},"subtitle":["Tackling Prostate-specific Antigen Decline Limitations in Patient With Metastatic Castration-resistant Prostate Cancer"],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005792","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"2024-11-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}